Population pharmacokinetics of tenofovir in AIDS patients.
about
Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infectionLow body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse eventsCan therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutationsPlasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients.Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patientsPhysiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal women.Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing studyAge-related differences in plasma and intracellular tenofovir concentrations in HIV-1-infected children, adolescents and adultsHigher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV.Clinical pharmacokinetics of antiretroviral drugs in older persons.Population Pharmacokinetics of Tenofovir in HIV-1-Uninfected Members of Serodiscordant Couples and Effect of Dose Reporting Methods.Estimation of tenofovir's population pharmacokinetic parameters without reliable dosing histories and application to tracing dosing history using simulation strategies.Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women.Steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected Chinese patients.ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen.Tenofovir plasma concentrations in post-menopausal versus pre-menopausal HIV-infected women.Virologic failure in an HIV-infected woman given desogestrel for excessive menstrual bleeding.Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients.
P2860
Q28481276-9ABA147E-DD94-4BEA-AAAD-32A7F531F9E0Q28535587-1C770BB9-B6F4-415A-B8A9-BC4635647D86Q33914723-ADAF8588-A658-4CFB-A477-E6E0EEFC3AA9Q33940140-389A5F53-AE15-497D-B7AC-D20171D64501Q35363649-A9ED35BF-2689-4BC5-B913-6C2C77392DFBQ35607723-57CA0638-20FA-4BF6-AE5D-95EEAD38C020Q36243626-AAEF5E06-47B3-4764-B726-B13A18E117C2Q36430073-A9843E00-1A28-4D26-A19B-FFACCFA8597DQ36432228-EBBA777D-B36B-40E4-8893-D0E0BCCD31EAQ36650454-7CEE794F-B1BC-46F3-8E57-2CEA801D629FQ36663586-B6FCC617-30FE-475F-8489-6D574B12CEC7Q36905884-55E63883-2E1B-4B79-BEC8-971EE448E713Q37203867-671EAF06-0DC8-4AA8-815A-EFEAF5DEFAFDQ37210864-52829958-205F-4494-B965-08C0F6891E9CQ37224902-FF94DFDF-C0B4-46B4-89D3-A86E9A99B2B8Q37641171-D8F5C0AA-680B-493B-AFE9-7AAF13275362Q38798813-A8930870-4443-4BA7-92F7-BF00850511B6Q42216997-BA331D90-7571-4651-A34A-D8EE6850AE74Q42279687-FD25662F-7807-47F0-A3C0-B131AFC40FEBQ44185379-4253CB12-C80C-4EED-8B3A-683A7FF6F664Q47633560-5E765657-09C2-4D02-9BDA-6A3584205BF7
P2860
Population pharmacokinetics of tenofovir in AIDS patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Population pharmacokinetics of tenofovir in AIDS patients.
@en
Population pharmacokinetics of tenofovir in AIDS patients.
@nl
type
label
Population pharmacokinetics of tenofovir in AIDS patients.
@en
Population pharmacokinetics of tenofovir in AIDS patients.
@nl
prefLabel
Population pharmacokinetics of tenofovir in AIDS patients.
@en
Population pharmacokinetics of tenofovir in AIDS patients.
@nl
P2093
P2860
P356
P1476
Population pharmacokinetics of tenofovir in AIDS patients.
@en
P2093
André Boibieux
Jean-Michel Livrozet
Jérôme Guitton
Laurent Cotte
Marie-Claude Gagnieu
Michel Tod
Mirna El Barkil
Patrick Miailhes
P2860
P304
P356
10.1177/0091270008322908
P577
2008-09-08T00:00:00Z